[Fixed pigmented erythema caused by levamisole administration].
BACKGROUND
Description of a case of fixed drug eruption induced by levamisole.


METHODS
Fixed toxic erythema with pigmentation was observed in a patient taking levamisole as an adjuvant to 5 fluorouracil chemotherapy for cancer of the colon. The imputability of levamisole was highly likely. Epicutaneous skin tests were negative.


CONCLUSIONS
Several types of skin eruptions have been described after intake of levamisole. It was highly likely that levamisole was implicated here and fixed pigmented erythema should be added to the list.
Service de Radiothérapie et de Carcinologie, CHRU Dupuytren, Limoges.
P
P
Clavère
A
A
Bonnafoux-Clavère
J L
JL
Delrous
J M
JM
Bonnetblanc
J P
JP
Olivier
D002288:Adenocarcinoma, Mucinous / Q000188:drug therapy; D002430:Cecal Neoplasms / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D007868:Leg Dermatoses / Q000139:chemically induced; D007978:Levamisole / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged
D007978:Levamisole
Erythème pigmenté fixe secondaire a l'administration de lévamisole.